Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medis’ cardiac imaging software solutions are widely used in clinical practice and research for quantitative analysis of cardiovascular images. Their Quantitative Flow Ratio (QFR®) technology has received a Class I recommendation in the 2024 ESC guidelines for management of chronic coronary syndromes. The company’s products have regulatory clearances including FDA 510(k), CE mark under MDR/EU MDD, Health Canada license, Japanese PMDA approval, and South Korean MFDS approval.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medis Medical Imaging.